title: American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.
authors.forename: Nelson B
authors.initials: NB
authors.lastname: Watts
authors.forename: John P
authors.initials: JP
authors.lastname: Bilezikian
authors.forename: Pauline M
authors.initials: PM
authors.lastname: Camacho
authors.forename: Susan L
authors.initials: SL
authors.lastname: Greenspan
authors.forename: Steven T
authors.initials: ST
authors.lastname: Harris
authors.forename: Stephen F
authors.initials: SF
authors.lastname: Hodgson
authors.forename: Michael
authors.initials: M
authors.lastname: Kleerekoper
authors.forename: Marjorie M
authors.initials: MM
authors.lastname: Luckey
authors.forename: Michael R
authors.initials: MR
authors.lastname: McClung
authors.forename: Rachel Pessah
authors.initials: RP
authors.lastname: Pollack
authors.forename: Steven M
authors.initials: SM
authors.lastname: Petak
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004704:Endocrinology / Q000592:standards*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis* / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012955:Societies, Medical / Q000592:standards; D014481:United States
chemical_list: D050071:Bone Density Conservation Agents